Tudorza Pressair Side Effects

Serious Side Effects of Tudorza Pressair

shortness of breath or difficulty breathing suddenly after inhaling Tudorza Pressair
trouble urinating, urinating more often, and pain or discomfort while urinating; enlarged prostate (in men)
increase in eye pressure
acute narrow-angle glaucoma with symptoms of eye redness, irritation or pain, blurry vision, seeing halos when looking at lights, and upset stomach or vomiting
symptoms of an allergic reaction: rash, red or itchy skin, hives, swelling of the mouth, tongue, throat or face and trouble breathing

Common Side Effects of Tudorza Pressair

headache
coughing
symptoms of a cold such as runny nose, fever, and sneezing

Warnings & Recalls for Tudorza Pressair

Tudorza Pressair and Pregnancy

Tudorza Pressair has been assigned a pregnancy Category C by the U.S. Food and Drug Administration. The effect on the fetus if taken during pregnancy, and the effect on a nursing baby when taken while breastfeeding is unknown. If you are pregnant, may become pregnant or are breastfeeding, ask your doctor about the risks and benefits of using Tudorza Pressair.

General Warnings

Using Tudorza Pressair may be dangerous for some patients. Let your doctor know about any medical conditions you may have including:

allergies you may have (especially to milk)
any eye problems such as glaucoma or acute
any prostate conditions or problems with your bladder

Be sure to tell your healthcare provider about any medications you are taking. Some drugs may interfere with Tudorza Pressair and cause serious side effects. Anticholinergenics (bronchodilators for treating breathing disorders) and atropine may interact with Tudorza Pressair.

Tudorza Pressair Treatment and Use

Tudorza Pressair | aclidinium bromide was approved by the U.S. Food and Drug Administration on July 23, 2012 as a long-acting muscarinic antagonist (LAMA) inhalant medicine marketed by Forest Laboratories Inc. for treating breathing disorders associated with chronic obstructive pulmonary disease (COPD or smoker’s cough). Tudorza Pressair may be prescribed for patients which chronic bronchitis or emphysema.

Tudorza Pressair should not be used in place of a rescue inhaler. Tudorza Pressair is for patients over 18 years of age.

How Does Tudorza Pressair Work?

Breathing disorders related to COPD are often caused by a constriction of muscles which decreases air flow. Tudorza Pressair is inhaled and absorbed into the lungs and airways, causing these muscles to relax. This reduces and prevents breathing problems and wheezing.

How to Use Tudorza Pressair

Tudorza Pressair comes in the form of a powder inhalant. Tudorza Pressair is typically prescribed to be taken twice each day in 400 mcg doses (once every 12 hours). Do not use more than prescribed to you by your doctor. Carefully follow all labeled instructions while taking Tudorza Pressair.

Contact your doctor immediately if your symptoms worsen.

Other Names for Tudorza Pressair

Brand name:

Tudorza Pressair

Generic name:

aclidinium bromide